Pay in installments of $7.25 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 2 - Jul 7
For Your Every Summer RSVP, with Code: SUMMER15
Description
apo-ENTERIT 50ml dropsKeynotes: Acute gastroenteritis with cramping. Can be used in combination with other remedies for chronic irritable bowel syndrome. Dosage: 20 to 30 drops per dose. For acute conditions, use dose as often as necessary to control symptoms, often beginning at 15 to 20 minute intervals. Once improvement is being seen, continue with 1 dose every 2 to 4 hours until condition is resolved. For chronic conditions, take with other remedies 2 or 3 times per

Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 1417 reviews
Sort
Product Reviews
★★★★★ 5
Excellent
Excellent
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 18, 2026
★★★★★ 5
Would recommend
Great multivitamin! I started to see a difference in my hair and skin.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 28, 2026
★★★★★ 4
Vitamins
Good quality
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 27, 2026
★★★★★ 5
Came on time
This definitely works. It gives me the vitamins Im lacking the most
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 30, 2026
★★★★★ 5
So far my energy level have increased, I will keep updating,
This is my very first bottle, so far great, I’ll keep posting my feedback
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 25, 2026




